Infective Endocarditis in Belgium: Prospective Data in Adults from the ESC EORP European Endocarditis Registry.

Belgium cardiac surgery infective endocarditis registry valve disease

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 15 01 2024
revised: 04 02 2024
accepted: 26 02 2024
medline: 9 4 2024
pubmed: 9 4 2024
entrez: 9 4 2024
Statut: epublish

Résumé

(1) Background: infective endocarditis (IE) is a significant health concern associated with important morbidity and mortality. Only limited, often monocentric, retrospective data on IE in Belgium are available. This prospective study sought to assess the clinical characteristics and outcomes of Belgian IE patients in the ESC EORP European endocarditis (EURO-ENDO) registry; (2) Methods: 132 IE patients were identified based on the ESC 2015 criteria and included in six tertiary hospitals in Belgium; (3) Results: The average Belgian IE patient was male and 62.8 ± 14.9 years old. The native valve was most affected (56.8%), but prosthetic/repaired valves (34.1%) and intracardiac device-related (5.3%) IE are increasing. The most frequently identified microorganisms were

Identifiants

pubmed: 38592201
pii: jcm13051371
doi: 10.3390/jcm13051371
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Abbott vascular Int
ID : 2011-2021
Organisme : Amgen Cardiovascular
ID : 2009-2018
Organisme : AstraZeneca
ID : 2014-2021
Organisme : Bayer AG
ID : 2009-2018
Organisme : Boehringer Ingelheim
ID : 2009-2019
Organisme : Boston Scientific
ID : 2009-2012
Organisme : The Bristol Myers Squibb and Pfizer Alliance
ID : 2011-2019
Organisme : Daiichi Sankyo Europe GmbH
ID : 2011-2020
Organisme : The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company
ID : 2014-2017
Organisme : Edwards
ID : 2016-2019
Organisme : Gedeon Richter Plc.
ID : 2014-2016
Organisme : Menarini Int. Op.
ID : 2009-2012
Organisme : MSD-Merck & Co.
ID : 2011-2014
Organisme : Novartis Pharma AG
ID : 2014-2020
Organisme : ResMed
ID : 2014-2016
Organisme : Sanofi
ID : 2009-2011
Organisme : SERVIER
ID : 2009-2021
Organisme : Vifor
ID : 2019-2022

Auteurs

Bram Roosens (B)

Centrum voor Hart-en Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.

Bernard Cosyns (B)

Centrum voor Hart-en Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.

Patrizio Lancellotti (P)

Department of Cardiology, Centre Hospitalier Universitaire Sart Tilman, 4000 Liège, Belgium.

Cécile Laroche (C)

EURObservational Research Programme, European Society of Cardiology, 06903 Biot, France.

Christine Selton-Suty (C)

EURObservational Research Programme, European Society of Cardiology, 06903 Biot, France.
Department of Cardiology, Centre Hospitalier Universitaire de Nancy, 54000 Nancy, France.

Agnès Pasquet (A)

Divisions of Cardiology and Cardiothoracic Surgery, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Johan De Sutter (J)

Hartcentrum Gent, Algemeen Ziekenhuis Maria Middelares, 9000 Ghent, Belgium.

Philippe Unger (P)

Centrum voor Hart-en Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.
Department of Cardiology, Centre Hospitalier Universitaire Saint-Pierre, 1000 Brussels, Belgium.

Bernard Paelinck (B)

Centrum voor Hart-en Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.
Department of Cardiology, Universitair Ziekenhuis (UZ) Antwerpen, 2650 Antwerp, Belgium.

Paul Vermeersch (P)

Centrum voor Hart-en Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.
Hartcentrum, Ziekenhuis Netwerk Antwerpen (ZNA), 2020 Antwerp, Belgium.

Andreea Motoc (A)

Centrum voor Hart-en Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.

Xavier Galloo (X)

Centrum voor Hart-en Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.

Bernard Iung (B)

Department of Cardiology, Bichat Hospital, APHP, Université Paris-Cité, 75018 Paris, France.

Gilbert Habib (G)

APHM, La Timone Hospital, Cardiology Department, Marseille, France & Aix Marseille University, IRD, APHM, MEPHI, IHU-Mediterranean Infection, 13005 Marseille, France.

Classifications MeSH